HBM Holdings Limited (HKG:2142)
15.69
+1.17 (8.06%)
Sep 30, 2025, 4:08 PM HKT
HBM Holdings Revenue
HBM Holdings had revenue of $101.32M USD in the half year ending June 30, 2025, with 147.13% growth. This brings the company's revenue in the last twelve months to $115.71M, up 60.25% year-over-year. In the year 2024, HBM Holdings had annual revenue of $38.10M, down -57.43%.
Revenue (ttm)
$115.71M
Revenue Growth
+60.25%
P/S Ratio
14.49
Revenue / Employee
$632.32K
Employees
183
Market Cap
13.17B HKD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 38.10M | -51.40M | -57.43% |
Dec 31, 2023 | 89.50M | 48.84M | 120.13% |
Dec 31, 2022 | 40.66M | 36.35M | 843.80% |
Dec 31, 2021 | 4.31M | -9.80M | -69.46% |
Dec 31, 2020 | 14.11M | 8.69M | 160.32% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines AG | 35.81B |
Hansoh Pharmaceutical Group Company | 14.45B |
JD Health International | 71.34B |
Innovent Biologics | 12.52B |
WuXi Biologics | 21.98B |
Sino Biopharmaceutical | 33.49B |
Akeso | 2.75B |
Sichuan Kelun-Biotech Biopharmaceutical | 1.64B |